Liquid Biopsies

Virtual Event, Worldwide : 18 - 19 November 2020

Scientific Programme

Wednesday 18th November 2020

14:00

WELCOME TO DAY 1

Chair: Caroline Dive

14:05

Nickolas Papadopoulos Johns Hopkins University, USA

"Development of multi-analyte blood tests for the earlier detection of cancer"

Q&A: 14:25 - 14:45

14:45

Exhibitor Introductions

14:50

Gabriella Sozzi Istituto Nazionale Tumori, Italy

"Biomarkers for early detection of lung cancer: the role of microRNAs"

Q&A: 15:10 - 15:30

15:30

5-minute break

15:35

INDUSTRY SYMPOSIUM - Thermo Fisher Scientific

Winand N.M. Dinjens University Medical Center Rotterdam, Netherlands

"4 year experience of cfDNA NGS analysis: is it ready for a clinical setting?"

16:00

Break

Coffee & stretching

16:15

Chris Abbosh UCL Cancer Institute, UK

"The clinical utility of ctDNA in minimal residual disease and the emergence of metastatic disease"

Q&A: 16:35 - 16:55

16:55

5-minute break

17:00

Riccardo Masina CRUK Cambridge Institute, UK

Proffered Paper 1: "Serial assessment of circulating tumour DNA in a phase 1b trial of ER positive metastatic breast cancer patients by multiple NGS-based approaches"

Q&A: 17:10 - 17:20

17:20

Francesca Chemi CRUK Manchester Institute, UK

Proffered Paper 2: "Investigating SCLC Acquired Chemotherapy Resistance Through Liquid Biopsy DNA Methylation Profiling"

Q&A: 17:30 - 17:40

17:40

5-minute break

17:45

Muhammed Murtaza University of Wisconsin, USA

"Monitoring treatment response in cancer patients using circulating tumor DNA analysis"

Q&A: 18:05 - 18:25

18:25

5-minute break

18:30

Poster Spotlights

3 top abstracts presented as 3 minute flash talks

18:40

END OF DAY 1 SUMMARY

Thursday 19th November 2020

13:00

Virtual Poster Discussion Session

14:00

WELCOME TO DAY 2

Chair: Evi Lianidou

14:05

Alberto Bardelli University of Torino, Italy

"Tracking and targeting colorectal cancer evolution"

Q&A: 14:25 - 14:45

14:45

5-minute break

14:50

Alicia-Marie Conway CRUK Manchester Institute, UK

Proffered Paper 3: "Identifying Liquid biomarkers to detect tissue of origin and direct therapy in Cancers of Unknown Primary: taking the ‘U’ out of ‘CUP’"

Q&A: 15:00 - 15:10

15:10

Jonine Figueroa University of Edinburgh, UK

Proffered Paper 4: "Circulating tumor DNA is readily detectable in plasma samples among Ghanaian breast cancer patients supporting liquid biopsy studies in sub-Saharan Africa"

Q&A: 15:20 - 15:30

15:30

5-minute break

15:35

INDUSTRY SYMPOSIUM - Roche

Aadel Chaudhuri Washington University Medical Center, USA

"ctDNA MRD detection and personalized oncogenomic analysis in oligometastatic colorectal cancer from plasma and urine"

16:00

Break

Coffee & stretching

16:15

Ellen Heitzer Medical University of Graz, Austria

"Assessment of ctDNA workflows for clinical decision making"

Q&A: 16:35 - 16:55

16:55

5-minute break

17:00

Giulia Siravegna Mass General Cancer Center, USA

"Circulating DNA analysis to uncover minimal residual disease and predict drug response in gastrointestinal cancer patients"

Q&A: 17:20 - 17:40

17:40

5-minute break

17:45

DISCUSSION FORUM

Caroline Dive, Carlos Caldas, Evi Lianidou

18:45

END OF DAY 2 SUMMARY

X [close tab]